Avience Biomedicals Ltd 52 Week High
Avience Biomedicals Ltd
NSE: Avience
YEARHIGH
Key Highlights
- The 52 Week HIGH of Avience Biomedicals Ltd is ₹ 414.95 as of 28 Jul 26 .
Company Fundamentals for Avience Biomedicals Ltd
Market Price of Avience Biomedicals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 28 Jul 2026 | 259.65 |
| 27 Jul 2026 | 259.5 |
| 24 Jul 2026 | 259.75 |
| 23 Jul 2026 | 251.2 |
| 22 Jul 2026 | 245.5 |
| 21 Jul 2026 | 251.5 |
| 20 Jul 2026 | 261.85 |
| 17 Jul 2026 | 222.85 |
| 16 Jul 2026 | 277.5 |
| 15 Jul 2026 | 273.75 |
Asset Value vs Market Value of Avience Biomedicals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Avience Biomedicals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Avience Biomedicals Ltd
Historical Net Profit of Avience Biomedicals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Avience Biomedicals Ltd
Avience Biomedicals Ltd News Hub
Avience Biomedicals schedules board meeting
Avience Biomedicals will hold a meeting of the Board of Directors of the Company on 13 July 2026.
Read more
14 Jul 26
NSE SME Avience Biomedicals debuts with a powerful heartbeat
The scrip was listed at Rs 395.20, a 90% premium to the initial public offer (IPO) price. The stock
Read more
25 Jun 26
